Literature DB >> 26279694

Preparation and Evaluation of (68)Ga-ECC as a PET Renal Imaging Agent.

Alireza Mirzaei1, Amir Reza Jalilian1, Ayuob Aghanejad1, Mohammad Mazidi1, Hassan Yousefnia1, Gholamali Shabani1, Khosro Ardaneh1, Parham Geramifar2, Davood Beiki2.   

Abstract

PURPOSE: Development of a gallium-68-labeled renal tracer can be a good substitute for Tc-99m, a known SPECT tracer. In this study, effort was made to develop (68)Ga-ethylenecysteamine cysteine ((68)Ga-ECC).
METHODS: Ga-ECC was prepared using generator-based (68)GaCl3 and ethylenecysteamine cysteine (ECC) at optimized conditions. Stability of the complex was checked in human serum followed by partition coefficient determination of the tracer. The biodistribution of the tracer in rats was studied using tissue counting and PET/CT imaging up to 120 min.
RESULTS: Ga-ECC was prepared at optimized conditions in 15 min at 90 °C (radiochemical purity ≈97 ± 0.88 % ITLC, >99 % HPLC, specific activity: 210 ± 5 GBq/mM). (68)Ga-ECC was a water-soluble complex based on partition coefficient data (log P; -1.378) and was stable in the presence of human serum for 2 h at 37 °C. The biodistribution of the tracer demonstrated high kidney excretion of the tracer in 10-20 min. The SUVmax ratios of the liver to left kidney were 0.38 and 0.39 for 30 and 90 min, respectively, indicating high kidney uptake.
CONCLUSION: Initial biodistribution results showed significant kidney and urinary excretion of the tracer comparable to that of the homologous (99m)Tc compound. The complex could be a possible PET kidney imaging agent with a fast imaging time.

Entities:  

Keywords:  68Ga; Biodistribution; Ethylenecysteamine cysteine; PET/CT; Renal agent

Year:  2015        PMID: 26279694      PMCID: PMC4532689          DOI: 10.1007/s13139-015-0323-7

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


  9 in total

1.  Synthesis and biological evaluation of the four isomers of technetium-99m labeled ethylenecysteamine cysteine ((99m)Tc-ECC), the mono-acid derivative of (99m)tc-L,L-ethylenedicysteine.

Authors:  H P Vanbilloen; B J Cleynhens; A M Verbruggen
Journal:  Nucl Med Biol       Date:  2000-02       Impact factor: 2.408

2.  N,N'-Ethylenedi-L-cysteine (EC) and Its Metal Complexes: Synthesis, Characterization, Crystal Structures, and Equilibrium Constants.

Authors:  Yuejin Li; Arthur E. Martell; Robert D. Hancock; Joseph H. Reibenspies; Carolyn J. Anderson; Michael J. Welch
Journal:  Inorg Chem       Date:  1996-01-17       Impact factor: 5.165

3.  N,N'-ethylene-di-L-cysteine (EC) complexes of Ga(III) and In(III): molecular modeling, thermodynamic stability and in vivo studies.

Authors:  C J Anderson; C S John; Y J Li; R D Hancock; T J McCarthy; A E Martell; M J Welch
Journal:  Nucl Med Biol       Date:  1995-02       Impact factor: 2.408

4.  Preparation of Ga-68-NOTA as a renal PET agent and feasibility tests in mice.

Authors:  Ji Youn Lee; Jae Min Jeong; Young Ju Kim; Hyuk-Jin Jeong; Yun-Sang Lee; Dong Soo Lee; June-Key Chung
Journal:  Nucl Med Biol       Date:  2013-12-01       Impact factor: 2.408

5.  A definition of substrate specificity in renal transport of organic anions.

Authors:  A Despopoulos
Journal:  J Theor Biol       Date:  1965-01       Impact factor: 2.691

6.  Assessment of human effective absorbed dose of 67 Ga-ECC based on biodistribution rat data.

Authors:  Saeed Shanehsazzadeh; Hassan Yousefnia; Afsaneh Lahooti; Samaneh Zolghadri; Amir Reza Jalilian; Hossien Afarideh
Journal:  Ann Nucl Med       Date:  2014-10-14       Impact factor: 2.668

7.  99mTc-MAEC complexes: new renal radiopharmaceuticals combining characteristics of (99m)Tc-MAG3 and (99m)Tc-EC.

Authors:  Andrew T Taylor; Malgorzata Lipowska; Lory Hansen; Eugene Malveaux; Luigi G Marzilli
Journal:  J Nucl Med       Date:  2004-05       Impact factor: 10.057

8.  Technetium-99m-L,L-ethylenedicysteine: a renal imaging agent. I. Labeling and evaluation in animals.

Authors:  A M Verbruggen; D L Nosco; C G Van Nerom; G M Bormans; P J Adriaens; M J De Roo
Journal:  J Nucl Med       Date:  1992-04       Impact factor: 10.057

9.  Synthesis and biological evaluation of technetium-99m MAG3 as a hippuran replacement.

Authors:  A R Fritzberg; S Kasina; D Eshima; D L Johnson
Journal:  J Nucl Med       Date:  1986-01       Impact factor: 10.057

  9 in total
  6 in total

Review 1.  A brief overview of metal complexes as nuclear imaging agents.

Authors:  Douglas S MacPherson; Kimberly Fung; Brendon E Cook; Lynn C Francesconi; Brian M Zeglis
Journal:  Dalton Trans       Date:  2019-10-07       Impact factor: 4.390

2.  Evaluating Ga-68 Peptide Conjugates for Targeting VPAC Receptors: Stability and Pharmacokinetics.

Authors:  Pardeep Kumar; Sushil K Tripathi; C P Chen; Eric Wickstrom; Mathew L Thakur
Journal:  Mol Imaging Biol       Date:  2019-02       Impact factor: 3.488

3.  Preclinical Study of 68Ga-DOTATOC: Biodistribution Assessment in Syrian Rats and Evaluation of Absorbed Dose in Human Organs.

Authors:  Mojdeh Naderi; Samaneh Zolghadri; Hassan Yousefnia; Ali Ramazani; Amir Reza Jalilian
Journal:  Asia Ocean J Nucl Med Biol       Date:  2016

Review 4.  Radiolabeled theranostics: magnetic and gold nanoparticles.

Authors:  Saeideh Same; Ayuob Aghanejad; Sattar Akbari Nakhjavani; Jaleh Barar; Yadollah Omidi
Journal:  Bioimpacts       Date:  2016-09-30

5.  Mucin-1 aptamer-armed superparamagnetic iron oxide nanoparticles for targeted delivery of doxorubicin to breast cancer cells.

Authors:  Ayuob Aghanejad; Hiwa Babamiri; Khosro Adibkia; Jaleh Barar; Yadollah Omidi
Journal:  Bioimpacts       Date:  2018-05-05

6.  Preclinical Evaluation of 68Ga-MAA from Commercial Available 99mTc-MAA Kit.

Authors:  Saeed Shanehsazzadeh; Amir Reza Jalilian; Afsaneh Lahooti; Parham Geramifar; Davood Beiki; Hassan Yousefnia; Amir Rabiee; Mohammad Mazidi; Seyedeh Fatemeh Mirshojaei; Stephan Maus
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.